FDA Inspection
Curia Massachusetts, Inc.Curia Massachusetts, Inc. – FDA Inspection, Jun 29, 2023
Record Details
This FDA Inspection record concerns Curia Massachusetts, Inc., with an inspection on June 29, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Cassandra L. Abellard (Company Rep)
- Holly Brevig (Investigator)
- Raeann R. Wu (Issuing Officer)
View Company Profile
ID · 216918cd-0ae5-4016-b191-ee609e34b39e
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1210781
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Curia Massachusetts, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| December 2, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 13, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 2, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 18, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Curia Massachusetts, Inc.
- FDA Inspection 1134063 - 2020-12-02
- FDA Inspection 1013010 - 2017-05-24
- FDA Inspection 988693 - 2016-07-13
- FDA Inspection 877350 - 2014-05-02
- FDA Inspection 841014 - 2013-07-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.